Bibliography
Export 2 results:
Filters: Keyword is *Antibodies, Monoclonal, Humanized/tu [Therapeutic Use] [Clear All Filters]
Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion//Transfusion. 2015;55(3):623-8.
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion. Transfusion//Transfusion. 2015;55(3):605-10.